Chemical inhibitors of NARFL manipulate cellular pathways that are crucial for its function, particularly those involved in the assembly and maintenance of iron-sulfur clusters within the mitochondria. Cyclosporin A operates by inhibiting calcineurin, thereby indirectly affecting the cellular homeostasis and energy metabolism that NARFL requires to function efficiently. Oligomycin A exerts its inhibitory effect on mitochondrial ATP synthase, disrupting ATP production and thus the energy balance necessary for NARFL's role in biosynthetic pathways. Antimycin A and Rotenone target the mitochondrial electron transport chain, inhibiting complexes III and I, respectively. This diminishes the assembly of iron-sulfur clusters, which are vital for NARFL activity. Chloroquine disrupts iron homeostasis by altering endosomal pH, potentially hindering the iron-sulfur cluster assembly that NARFL facilitates.
Continuing with this theme, Deferoxamine chelates iron, directly impeding the availability of this essential metal for the iron-sulfur cluster assembly that NARFL is associated with. Zileuton's inhibition of 5-lipoxygenase alters leukotriene synthesis, which can indirectly modify the redox state within cells and thus affect the assembly of iron-sulfur clusters, leading to the inhibition of NARFL. Fenamiphos, an acetylcholinesterase inhibitor, may lead to oxidative stress, which in turn can impair the iron-sulfur cluster assembly machinery, thus inhibiting NARFL. The proteasome inhibitor Bortezomib disrupts protein homeostasis, which could lead to an indirect inhibition of NARFL by affecting its involvement in the iron-sulfur cluster assembly processes. Stattic, as a STAT3 inhibitor, changes gene expression profiles, potentially leading to a decrease in the cellular processes requiring NARFL. PD 98059 inhibits MEK in the MAPK pathway, potentially disrupting signaling pathways reliant on iron-sulfur cluster biogenesis, thus indirectly affecting NARFL. Lastly, Genistein, a tyrosine kinase inhibitor, could hinder signaling pathways that depend on the proper assembly of iron-sulfur clusters, which is necessary for the functional activity of NARFL in the cell.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059 is an inhibitor of MEK, which is upstream of ERK in the MAPK pathway. Inhibition of this pathway can disrupt cellular signaling that requires iron-sulfur cluster biogenesis, thus indirectly inhibiting NARFL. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor. By inhibiting specific kinases, it could disrupt signaling pathways that rely on the iron-sulfur cluster assembly, which is necessary for NARFL's function. | ||||||